Novartis Breaks Ground on New Influenza Vaccines Manuf



Uploaded by: MultiVuOnline
Video Description:
Novartis Breaks Ground on New Influenza Vaccines Manufacturing Facility
Novartis has broken ground on construction of the first cell culture-derived influenza vaccines manufacturing plant in the United States. Once completed, the Holly Springs, North Carolina facility is expected to annually produce up to 50 million doses of seasonal trivalent flu vaccines or up to 15
0 million monovalent doses within six months of a pandemic declaration. Completion of the facility is expected in late 2009, and following validation and FDA approval, initial vaccine production at the site is anticipated for 2011. An investment of approximately $600 million, which includes a $220
million grant from the US Department of Health and Human Services is planned to complete the Holly Springs facility. In addition to the significant investment in plant construction and equipment, the site will bring more than 350 new job opportunities to the area, including entry level, technicians
, supervisors and management.


Tags for this video: 29495 cell culture Holly Influenza Multivu Novartis Springs Vaccine www.novar

Find more videos in the "News" category
See more videos uploaded by MultiVuOnline

Related Videos
Novartis, Stop It (AIDS Patent)Actiedag tegen Novartis, Ciba & Notox (9-11-2007) Yellow Fever Vaccine Production on the Rise
novartis-stop-it-aids-patent.htmlnovartis-stop-it-aids-patent.htmlnovartis-stop-it-aids-patent.html
Novartis DiagnosticsNOVARTISLias speech outside Novartis
novartis-stop-it-aids-patent.htmlnovartis-stop-it-aids-patent.htmlnovartis-stop-it-aids-patent.html


Share This Video:       StumbleUpon       del.icio.us       Reddit       digg       Furl       Spurl       Simpy       YahooMyWeb


Comments for this video: Show || Hide
Comments for this video on YouTube



Tell a friend:


URL 
Embed Code